Drug recall · January 7, 2026
Wegovy (semaglutide) Injection recall
Why: Presence of Particulate Matter: Hair was found in a prefilled syringe
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14
- Lots / codes
Lot #: RZFYK06, RZFYA53; Exp Date 3/31/2027
- Quantity
- N/A
- Company
- Novo Nordisk Inc., Plainsboro, NJ
- Distribution
- Nationwide within the United States.
- Initiated
- December 19, 2025 · Voluntary: Firm initiated
- Classified
- December 31, 2025
- Reported
- January 7, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Wegovy
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.